arrow
S

S. Vergèz

gustave roussy
H指数:35
被引数:4,756

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of surgical reporting and adequacy of surgical treatment in salivary gland cancer: a quality assurance ancillary study of the GORTEC 2016-02 SANTAL trial

唾液腺癌手术报告质量和手术治疗充分性:GORTEC 2016-02 SANTAL试验的质量保证辅助研究

EJSO
IF2.9
2026-08-010
PRE
European surgical guidelines: transoral robotic surgery for head and neck cancers
2026-01-210
OAAI
Survival rates and prognostic factors of 118 sinonasal sarcomas among adolescents and adults: a national database REFCOR study

118例青少年及成人鼻窦肉瘤的生存率及预后因素:一项国家数据库REFCOR研究

2025-06-210
PRE
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study
2024-12-010
OAAI
Malignant salivary gland tumors of the tongue: A multicenter REFCOR study
2024-09-200
PRE
Immunoscore-IC predicts nivolumab efficacy as adjuvant treatment after salvage surgery in head and neck cancer squamous cell carcinoma: The ADJORL1 trial

Immunoscore-IC预测头颈鳞状细胞癌挽救性手术后辅助治疗中使用nivolumab的疗效:ADJORL1试验

2024-09-010
PRE
Carcinomas of the external auditory canal: Management and results: A multicenter REFCOR propensity score matching study
2024-04-010
OA
Functional or radical surgical treatment of laryngeal chondrosarcoma, analysis of survival and prognostic factors: A REFCOR and NetSarc-ResOs multicenter study of 74 cases
EJSO
IF2.9
2024-02-013
PRE
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity
2023-12-182
OAAI
Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR)

80例鼻窦未分化癌的治疗。法国罕见头颈癌网络 (REFCOR) 的回顾性多中心研究

EJSO
IF2.9
2023-12-012
OAAI
Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients
2023-05-014
PRE